[email protected] +357 96 030922 Contact Us | FAQ |
Advanced search

Middle East Cell Line Development Market Size, Share & Trends Analysis Report By Product & Services (Reagents And Media, Equipment, Accessories and consumables, Services), By Source, By Type of Cell Line, By Source, By Application, By Country, And Segment Forecasts, 2025 - 2033

December 2025 | 150 pages | ID: MB6E1171A3D3EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

The Middle East cell line development market size was valued at USD 164.9 million in 2024 and is projected to grow to USD 340.9 million by 2033, registering a CAGR of 8.38% between 2025 and 2033. The growth is driven by increasing investments in biopharmaceutical research, expanding contract development and manufacturing services, and rising demand for novel therapeutics and personalized medicine in the region.

Advancements in Bioprocessing Technologies

Rapid advances in bioprocessing technologies are driving the Middle East cell line development market. Automated cell culture, high-throughput screening, and 3D cell culture techniques are increasingly used by research institutions, biotech firms, and pharmaceutical companies, enabling faster, more consistent, and reproducible cell line development. This accelerates the creation of monoclonal antibodies, recombinant proteins, and other biologics to meet growing demand for innovative therapeutics.

Middle East Cell Line Development Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the Middle East cell line development market on the basis of product & services, source, type of cell lines, application, and country:
  • Product & Service Outlook (Revenue, USD Million, 2021 - 2033)
  • Reagents and media
  • Equipment
    • Automated Systems
    • Centrifuges
    • Bioreactors
    • Storage equipment
    • Others
  • Accessories and consumables
  • Services
  • Source Outlook (Revenue, USD Million, 2021 - 2033)
  • Mammalian cell line
  • Non-mammalian cell line
    • Insects
    • Amphibians
  • Type of Cell Lines Outlook (Revenue, USD Million, 2021 - 2033)
  • Recombinant cell lines
  • Hybridomas
  • Continuous cell lines
  • Primary cell lines
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Bioproduction
  • Drug discovery
  • Toxicity testing
  • Tissue engineering & Regenerative Medicine
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • Middle East
    • Saudi Arabia
    • UAE
    • Kuwait
    • Oman
    • Qatar
    • Rest of Middle East
This report can be delivered to the clients within 2 Business Days
CHAPTER 1. METHODOLOGY AND SCOPE

1.1. Market Segmentation and Scope
  1.1.1. Product & Services
  1.1.2. Source
  1.1.3. Type of Cell Lines
  1.1.4. Application
1.2. Market Definitions
1.3. Information analysis
1.4. Market formulation & data visualization
1.5. Data validation & publishing
1.6. Information Procurement
  1.6.1. Primary Others
1.7. Information or Data Analysis
1.8. Market Formulation & Validation
1.9. Market Model
1.10. Objectives

CHAPTER 2. EXECUTIVE SUMMARY

2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot

CHAPTER 3. MARKET VARIABLES, TRENDS, & SCOPE

3.1. Market Lineage Outlook
  3.1.1. Parent Market Outlook
  3.1.2. Related/Ancillary Market Outlook
3.2. Market Trends and Outlook
3.3. Market Dynamics
  3.3.1. Market Driver Analysis
    3.3.1.1. Advancements in Bioprocessing Technologies
    3.3.1.2. Increasing Clinical Trials and Drug Development
3.4. Market Restraint Analysis
    3.4.1.1. Presence of complicated regulatory framework
3.5. Business Environment Analysis
  3.5.1. PESTEL Analysis
  3.5.2. Porter?s Five Forces Analysis

CHAPTER 4. PRODUCT & SERVICES BUSINESS ANALYSIS

4.1. Product & Services Segment Dashboard
4.2. Middle East Cell Line Development Market: Product & Services Movement Analysis
4.3. Middle East Cell Line Development Market Size & Trend Analysis, by Product & Services, 2021 to 2033 (USD Million)
4.4. Reagents and Media
  4.4.1. Reagents and Media Market, 2021 - 2033 (USD Million)
4.5. Equipment
  4.5.1. Equipment Market, 2021 - 2033 (USD Million)
  4.5.2. Automated Systems
    4.5.2.1. Automated Systems Market, 2021 - 2033 (USD Million)
  4.5.3. Centrifuges
    4.5.3.1. Centrifuges Market, 2021 - 2033 (USD Million)
  4.5.4. Bioreactors
    4.5.4.1. Bioreactors Market, 2021 - 2033 (USD Million)
  4.5.5. Storage Equipment
    4.5.5.1. Storage Equipment Market, 2021 - 2033 (USD Million)
  4.5.6. Others
    4.5.6.1. Others Market, 2021 - 2033 (USD Million)
4.6. Accessories and Consumables
  4.6.1. Accessories and Consumables Market, 2021 - 2033 (USD Million)
4.7. Services
  4.7.1. Services Market, 2021 - 2033 (USD Million)

CHAPTER 5. SOURCE BUSINESS ANALYSIS

5.1. Source Segment Dashboard
5.2. Middle East Cell Line Development Market: Source Movement Analysis
5.3. Middle East Cell Line Development Market Size & Trend Analysis, by Source, 2021 to 2033 (USD Million)
5.4. Mammalian Cell Line
  5.4.1. Mammalian Cell Line Market, 2021 - 2033 (USD Million)
5.5. Non-Mammalian Cell Line
  5.5.1. Non-Mammalian Cell Line Market, 2021 - 2033 (USD Million)
  5.5.2. Insects
    5.5.2.1. Insects Market, 2021 - 2033 (USD Million)
  5.5.3. Amphibians
    5.5.3.1. Amphibians Market, 2021 - 2033 (USD Million)

CHAPTER 6. TYPE OF CELL LINES BUSINESS ANALYSIS

6.1. Type of Cell Lines Segment Dashboard
6.2. Middle East Cell Line Development Market: Type of Cell Lines Movement Analysis
6.3. Middle East Cell Line Development Market Size & Trend Analysis, by Type of Cell Lines, 2021 to 2033 (USD Million)
6.4. Recombinant Cell Lines
  6.4.1. Recombinant Cell Lines Market, 2021 - 2033 (USD Million)
6.5. Hybridomas
  6.5.1. Hybridomas Market, 2021 - 2033 (USD Million)
6.6. Continuous Cell Lines
  6.6.1. Continuous Cell Lines Market, 2021 - 2033 (USD Million)
6.7. Primary Cell Lines
  6.7.1. Primary Cell Lines Market, 2021 - 2033 (USD Million)

CHAPTER 7. APPLICATION BUSINESS ANALYSIS

7.1. Application Segment Dashboard
7.2. Middle East Cell Line Development market: Application Movement Analysis
7.3. Middle East Cell Line Development Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
7.4. Bioproduction
  7.4.1. Bioproduction Market, 2021 - 2033 (USD Million)
7.5. Drug Discovery
  7.5.1. Drug Discovery Market, 2021 - 2033 (USD Million)
7.6. Toxicity Testing
  7.6.1. Toxicity Testing Market, 2021 - 2033 (USD Million)
7.7. Tissue Engineering & Regenerative Medicine
  7.7.1. Tissue Engineering & Regenerative Medicine Market, 2021 - 2033 (USD Million)
7.8. Others
  7.8.1. Others Market, 2021 - 2033 (USD Million)

CHAPTER 8. COUNTRY BUSINESS ANALYSIS

8.1. Middle East Cell Line Development Market Share By Country, 2024 & 2033
8.2. Middle East
  8.2.1. MEA Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
  8.2.2. Saudi Arabia
    8.2.2.1. Key Country Dynamics
    8.2.2.2. Competitive Scenario
    8.2.2.3. Regulatory Framework
    8.2.2.4. Saudi Arabia Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
  8.2.3. UAE
    8.2.3.1. Key Country Dynamics
    8.2.3.2. Competitive Scenario
    8.2.3.3. Regulatory Framework
    8.2.3.4. UAE Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
  8.2.4. Kuwait
    8.2.4.1. Key Country Dynamics
    8.2.4.2. Competitive Scenario
    8.2.4.3. Regulatory Framework
    8.2.4.4. Kuwait Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
  8.2.5. Oman
    8.2.5.1. Key Country Dynamics
    8.2.5.2. Competitive Scenario
    8.2.5.3. Regulatory Framework
    8.2.5.4. Oman Middle East Cell Line Development Market, 2021 - 2033 (USD Million)
  8.2.6. Qatar
    8.2.6.1. Key Country Dynamics
    8.2.6.2. Competitive Scenario
    8.2.6.3. Regulatory Framework
    8.2.6.4. Qatar Middle East Cell Line Development Market, 2021 - 2033 (USD Million)

CHAPTER 9. COMPETITIVE LANDSCAPE

9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Position Analysis, 2024
9.4. Company Profiles/Listing
  9.4.1. Thermo Fisher Scientific Inc.
    9.4.1.1. Overview
    9.4.1.2. Financial Performance
    9.4.1.3. Product Benchmarking
    9.4.1.4. Strategic Initiatives
  9.4.2. Danaher
    9.4.2.1. Overview
    9.4.2.2. Financial Performance
    9.4.2.3. Product Benchmarking
    9.4.2.4. Strategic Initiatives
  9.4.3. Merck KGaA
    9.4.3.1. Overview
    9.4.3.2. Financial Performance
    9.4.3.3. Product Benchmarking
    9.4.3.4. Strategic Initiatives
  9.4.4. Sartorius AG
    9.4.4.1. Overview
    9.4.4.2. Financial Performance
    9.4.4.3. Product Benchmarking
    9.4.4.4. Strategic Initiatives
  9.4.5. Lonza
    9.4.5.1. Overview
    9.4.5.2. Financial Performance
    9.4.5.3. Product Benchmarking
    9.4.5.4. Strategic Initiatives
  9.4.6. WuXi PharmaTech
    9.4.6.1. Overview
    9.4.6.2. Financial Performance
    9.4.6.3. Product Benchmarking
    9.4.6.4. Strategic Initiatives
  9.4.7. Advanced Instruments
    9.4.7.1. Overview
    9.4.7.2. Financial Performance
    9.4.7.3. Product Benchmarking
    9.4.7.4. Strategic Initiatives
  9.4.8. Berkeley Lights
    9.4.8.1. Overview
    9.4.8.2. Financial Performance
    9.4.8.3. Product Benchmarking
    9.4.8.4. Strategic Initiatives
  9.4.9. Creative BioLabs
    9.4.9.1. Overview
    9.4.9.2. Financial Performance
    9.4.9.3. Product Benchmarking
    9.4.9.4. Strategic Initiatives
  9.4.10. Corning Inc.
    9.4.10.1. Overview
    9.4.10.2. Financial Performance
    9.4.10.3. Product Benchmarking
    9.4.10.4. Strategic Initiatives
LIST OF TABLES


Table 1 List Of Secondary Sources
Table 2 List Of Abbreviations
Table 3 Middle East cell line development market by product & services, 2021 - 2033 (USD Million)
Table 4 Middle East cell line development market by source, 2021 - 2033 (USD Million)
Table 5 Middle East cell line development market by type of cell line, 2021 - 2033 (USD Million)
Table 6 Middle East cell line development market by application, 2021 - 2033 (USD Million)
Table 7 Middle East cell line development market by country, 2021 - 2033 (USD Million)
Table 8 Oman cell line development market by product & services, 2021 - 2033 (USD Million)
Table 9 Oman cell line development market by source, 2021 - 2033 (USD Million)
Table 10 Oman cell line development market by type of cell line, 2021 - 2033 (USD Million)
Table 11 Oman cell line development market by application, 2021 - 2033 (USD Million)
Table 12 Oman cell line development market by product & services, 2021 - 2033 (USD Million)
Table 13 Saudi Arabia cell line development market by source, 2021 - 2033 (USD Million)
Table 14 Saudi Arabia cell line development market by type of cell line, 2021 - 2033 (USD Million)
Table 15 Saudi Arabia cell line development market by application, 2021 - 2033 (USD Million)
Table 16 UAE cell line development market by product & services, 2021 - 2033 (USD Million)
Table 17 UAE cell line development market by source, 2021 - 2033 (USD Million)
Table 18 UAE cell line development market by type of cell line, 2021 - 2033 (USD Million)
Table 19 UAE cell line development market by application, 2021 - 2033 (USD Million)
Table 20 Kuwait cell line development market by product & services, 2021 - 2033 (USD Million)
Table 21 Kuwait cell line development market by source, 2021 - 2033 (USD Million)
Table 22 Kuwait cell line development market by type of cell line, 2021 - 2033 (USD Million)
Table 23 Kuwait cell line development market by application, 2021 - 2033 (USD Million)
Table 24 Qatar cell line development market by product & services, 2021 - 2033 (USD Million)
Table 25 Qatar cell line development market by source, 2021 - 2033 (USD Million)
Table 26 Qatar cell line development market by type of cell line, 2021 - 2033 (USD Million)
Table 27 Qatar cell line development market by application, 2021 - 2033 (USD Million)
Table 28 Qatar cell line development market by product & services, 2021 - 2033 (USD Million)
LIST OF FIGURES


Fig. 1 Market Others process
Fig. 2 Data triangulation techniques
Fig. 3 Primary Others pattern
Fig. 4 Market Others approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2024 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Porter?s analysis
Fig. 13 SWOT analysis
Fig. 14 Middle East cell line development market: Product & services outlook and key takeaways
Fig. 15 Middle East cell line development market: Product & services movement analysis
Fig. 16 Reagents and media market, 2021 - 2033 (USD Million)
Fig. 17 Equipment market, 2021 - 2033 (USD Million)
Fig. 18 Automated systems market, 2021 - 2033 (USD Million)
Fig. 19 Centrifuges market, 2021 - 2033 (USD Million)
Fig. 20 Bioreactors market, 2021 - 2033 (USD Million)
Fig. 21 Storage equipment market, 2021 - 2033 (USD Million)
Fig. 22 Others market, 2021 - 2033 (USD Million)
Fig. 23 Accessories and consumables market, 2021 - 2033 (USD Million)
Fig. 24 Services market, 2021 - 2033 (USD Million)
Fig. 25 Middle East cell line development market: Source outlook and key takeaways
Fig. 26 Middle East cell line development market: Source movement analysis
Fig. 27 Mammalian cell line market, 2021 - 2033 (USD Million)
Fig. 28 Non-Mammalian Cell Line Market, 2021 - 2033 (USD Million)
Fig. 29 Insects market, 2021 - 2033 (USD Million)
Fig. 30 Amphibians market, 2021 - 2033 (USD Million)
Fig. 31 Middle East cell line development market: Type of cell line outlook and key takeaways
Fig. 32 Middle East cell line development market: Type of cell line movement analysis
Fig. 33 Recombinant cell lines market, 2021 - 2033 (USD Million)
Fig. 34 Hybridomas market, 2021 - 2033 (USD Million)
Fig. 35 Continuous cell lines market, 2021 - 2033 (USD Million)
Fig. 36 Primary cell lines market, 2021 - 2033 (USD Million)
Fig. 37 Middle East cell line development market: Application outlook and key takeaways
Fig. 38 Middle East cell line development market: Application movement analysis
Fig. 39 Bioproduction market, 2021 - 2033 (USD Million)
Fig. 40 Drug discovery market, 2021 - 2033 (USD Million)
Fig. 41 Toxicity testing market, 2021 - 2033 (USD Million)
Fig. 42 Tissue engineering market, 2021 - 2033 (USD Million)
Fig. 43 Others market, 2021 - 2033 (USD Million)
Fig. 44 Middle East cell line development market: Country outlook and key takeaways
Fig. 45 Saudi Arabia key country dynamics
Fig. 46 Saudi Arabia cell line development market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 47 UAE key country dynamics
Fig. 48 UAE cell line development market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 49 Kuwait key country dynamics
Fig. 50 Kuwait cell line development market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 51 Oman key country dynamics
Fig. 52 Oman cell line development market estimates and forecast, 2021 - 2033 (USD Million)
Fig. 53 Qatar key country dynamics
Fig. 54 Qatar cell line development market estimates and forecast, 2021 - 2033 (USD Million)

More Publications

Need Help?

Ask a Question

Market Reports

All Categories